Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy

Causes and treatments for heart failure (HF) have been investigated for over a century culminating in data that have led to numerous pharmacological and surgical therapies. Unfortunately, to date, even with the most current treatments, HF remains a progressive disease with no therapies targeting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallicano, G. Ian, Fu, Jiayu, Mahapatra, Samiksha, Sharma, Michael V. R., Dillon, Conor, Deng, Claire, Zahid, Maliha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317130/
https://www.ncbi.nlm.nih.gov/pubmed/35890169
http://dx.doi.org/10.3390/ph15070871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317130/
https://www.ncbi.nlm.nih.gov/pubmed/35890169
http://dx.doi.org/10.3390/ph15070871

Ejemplares similares